Download full-text PDF

Source
http://dx.doi.org/10.1016/s0041-1345(01)01984-4DOI Listing

Publication Analysis

Top Keywords

inhibition cyclosporin-resistant
4
cyclosporin-resistant b-cell
4
b-cell antigen
4
antigen responses
4
responses pyrazoles
4
pyrazoles tool
4
tool identification
4
identification novel
4
novel molecular
4
molecular mechanisms
4

Similar Publications

Human immunodeficiency virus type 1 mutants that are resistant to inhibition by cyclosporins arise spontaneously in vitro during propagation in a HeLa-CD4+ cell line in the presence of a nonimmunosuppressive analog of cyclosporin A. Interestingly, the phenotype of all of the mutants examined is drug resistant and drug dependent, with both cyclosporin A and its analog. Four independently isolated mutants have been analyzed genetically by construction of recombinant proviruses in the NL4-3 parental strain background and subsequent testing of the chimeric viruses in HeLa cells.

View Article and Find Full Text PDF

Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A.

Nature

August 1991

Beckman Center for Molecular and Genetic Medicine, Howard Hughes Medical Institute, Stanford University Medical School, California 94305.

Cyclosporin A and FK506 inhibit T- and B-cell activation and other processes essential to an effective immune response. In T lymphocytes these drugs disrupt an unknown step in the transmission of signals from the T-cell antigen receptor to cytokine genes that coordinate the immune response. The putative intracellular receptors for FK506 and cyclosporin are cis-trans prolyl isomerases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!